(NASDAQ:ADVM), REDWOOD CITY, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that Laurent Fischer, MD, President and Chief Executive Officer, and Szilard Kiss, MD, Distinguished Professor of Ophthalmology, Professor of Genetic Medicine and Board Member of Adverum, will participate in a fireside chat at the H.C. Wainwright 5th Annual […]

(NasdaqGM:KROS), LEXINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (“TGF-ss”) family of proteins, today reported

(NASDAQ:SNDX), NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on August 1, 2025 the Company granted inducement awards to purchase up to 48,600 shares of common stock to seven new employees under the Company's 2023 Inducement Plan. The stock options

(NASDAQ:SLNO), REDWOOD CITY, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided an update on the U.S. launch of VYKATTM XR and reported financial results for the second quarter ended June 30, 2025. Second Quarter 2025 and

(NASDAQ:DUOL), PITTSBURGH, Aug. 06, 2025 (GLOBE NEWSWIRE) — Duolingo, Inc. (NASDAQ: DUOL) announced results for the second quarter ended June 30, 2025 in a shareholder letter that is posted on its Investor Relations website at investors.duolingo.com. “We exceeded our own high expectations for bookings and revenue this quarter, and did it while expanding profitability,” said

(NASDAQ:CSWC), DALLAS, Aug. 06, 2025 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest,” “CSWC” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced its financial results for the first fiscal quarter ended June 30, 2025.

(NASDAQ:PRAX), BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that on August 1, 2025, the Compensation Committee of Praxis' Board of Directors granted restricted stock

(NASDAQ:VYGR), – Cash runway extended into 2028; expected to enable multiple meaningful clinical data read-outs – – APOE program added to pipeline; fourth asset in industry-leading Alzheimer's disease franchise – – 11 partnered programs with potential for $2.6B in development-stage milestone payments – LEXINGTON, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq:

Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation GlobeNewswire August 06, 2025 Data from patients who remained on tegoprubart for a year showed overall mean 12-month eGFR of approximately 68 mL/min/1.73 m(2) post-transplant Preliminary iBox data, a key biomarker of kidney function and immunologic response,

Duolingo Doubles Down on Delight with Acquisition of Music Gaming Startup NextBeat's Innovative Team London-based team brings deep expertise in music games, licensing, and interactive design GlobeNewswire August 06, 2025 PITTSBURGH, Aug. 06, 2025 (GLOBE NEWSWIRE) — Duolingo, Inc. (Nasdaq: DUOL), the world's leading mobile learning platform, announced today it has acquired the team behind